-
Ortho Evra “Black-Box” Warning About Risks Of Blood Clots Added To Package Insert In March 2011
Warnings Increased About Risk Of Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com)In March 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc. revised the Prescribing Information (more commonly called…
-
Reclast “Dear Doctor” Letter For Kidney Problems Should Be Sent By Novartis In U.S.
Public Citizen March 2011 Letter To FDA Points To Aclasta Safety Alert Material Sent In Canada During October 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: On September 1, 2011 the FDA announced…
-
730 NuvaRing Lawsuits Filed As Of December 31, 2010 Per Merck Annual Report
610 Cases Were In Federal Court NuvaRing MDL And 110 Complaints Filed In New Jersey State Court (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: First NuvaRing Lawsuit Trials Against Merck Are Currently Scheduled…
-
Another Rather “Odd” YAZ Label Change By Bayer: March 2011
Provides New Warnings About Certain Side Effects As Regards ALL Birth Control Pills (Not Specific To YAZ) (Posted by Tom Lamb at DrugInjuryWatch.com) The bottom line is this: There is nothing specific about YAZ…
-
Generic Drug Company Should Not Be Allowed To Use Federal Preemption To Defeat Lawsuits
U. S. Supreme Court Will Hear Oral Arguments On This Legal Issue In Drug Injury Lawsuit Involving Gladys Mensing (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: The Pliva, Inc., et al. v. Mensing case was…
